Harvey just announced Tenet, its first in-house AI model, cutting reliance on suppliers like Anthropic and OpenAI. Convenient timing, given both are now circling the legal market themselves. Thomson Reuters beat it to the punch though, quietly rolling out its own model, Thomson, a few weeks earlier: Point Blank

⚖️ Employment: The Victorian Government has flagged what it's calling the toughest workplace surveillance laws in the country, if Labor wins November's election. The proposal would force employers to notify and consult staff before rolling out monitoring, ban covert surveillance except where unlawful conduct is suspected, and stop AI tracking things like bathroom breaks without genuine justification. Employers would also need human review of significant automated decisions affecting workers' rights, and staff would get a right to access their own surveillance data. It follows a parliamentary inquiry that found Victorian employers generally aren't required to disclose surveillance at all: Lander & Rogers

⚖️ M&A: Grant Thornton shareholders were set to receive different amounts of cash and scrip for their shares under a buyout by Turbo Fast Track Buyer, yet the NSW Supreme Court let them all vote at a single meeting. No independent expert report, no shareholder info line either. Black J reasoned the payout differences simply mirrored Grant Thornton's existing dividend structure, and its 99% partner shareholder base was financially savvy enough not to need the usual protections. A $31m incentive pool for 83 partners didn't change that. Bear in mind that this flexibility is for unlisted, sophisticated shareholder bases only, not your standard listed scheme: Clayton Utz

⚖️ Class Actions: Mallesons' latest Class Actions Review found new filings dropped from a record 80 to 46, the lowest since 2016/17. But $1.65bn in settlements were approved, Mallesons' second-highest annual total on record, including five over $100m each. Brambles and Worley delivered the first plaintiff wins on causation and loss in shareholder claims, and the High Court's pending Zonia decision could reshape how shareholder loss is calculated and proven going forward. Victoria stayed the busiest court and the only jurisdiction with group costs orders, while 15 of the 46 new actions overlapped with a regulatory probe: Mallesons

Australian scientist Georgina Long helped lead a 1,100+ patient trial of Moderna’s personalised mRNA cancer vaccine, which has shown promising late-stage results in preventing melanoma from returning or spreading. Long says it's the first time a cancer vaccine has actually worked, after 50 years of trying: AFR

OpenAI just gave ChatGPT the ability to read, write and send iMessages on Mac, plus summarise your conversations. It runs locally and needs your consent first, but it's still an OpenAI tool poking around inside Apple's privacy-obsessed ecosystem. The timing is interesting — Apple sued OpenAI last month for trade secret theft: Bloomberg

🚀 Anthropic is gunning to match or beat SpaceX's record IPO as it preps a public filing as soon as this month. The Claude maker raised US$65bn in May at a US$965bn valuation, but posted a ~$42bn net loss in 2025: Bloomberg

🙅 Morrison is reportedly set to walk away from a stake in Optus, deeming the $3bn telco too hard a deal to pursue. It follows Macquarie's tilt falling through and Brookfield's 20% play collapsing in 2024 over profitability concerns: The Australian